Navigation Links
Lilly Oncology to Present New Data on Nine of Its Pipeline Molecules at ASCO 2011
Date:5/16/2011

INDIANAPOLIS, May 16, 2011 /PRNewswire/ -- Data on nine Lilly Oncology molecules in development will be presented during the 47th Annual Meeting of the American Society of Clinical Oncology (ASCO) held in Chicago, Ill. from June 3 – 7, 2011.  Lilly Oncology's pipeline is one of the largest in the industry, with more than 30 molecules in development to treat various types of cancer.  

Nearly all of these pipeline molecules are being evaluated for certain biomarkers or genetic mutations that can help researchers identify which patients are most likely to respond to these medicines, and as importantly, which are not.  

At ASCO, Lilly will present Phase II data on two fully human IgG1 monoclonal antibodies: cixutumumab for the treatment of patients with advanced or metastatic soft tissue sarcoma and Ewing family of tumors; and ramucirumab for the treatment of locally advanced or metastatic breast cancer.  Lilly will also present data on a Phase I study of LY2127399, a human anti-BAFF antibody for patients with previously-treated multiple myeloma.  Additionally, Lilly will present data from several studies of enzastaurin, a selective serine-threonine kinase inhibitor that targets the PKC Beta and PI3/AKT pathways.

"Lilly is very much in alignment with this year's ASCO conference theme, 'Patients, Pathways, Progress,'" said Richard Gaynor, M.D., vice president, product development and medical affairs for Lilly Oncology.  "Our extensive oncology pipeline targets important pathways and specific genetic mutations that can lead to cancer, which we hope will enable us to come up with better therapies, more quickly.  This is part of our commitment to changing the world of cancer care," he added.    

Select studies, as well as the times and locations of the data sessions, are highlighted below.

Cixutumumab (IMC-A12)

  • Abstract # 10004: Oral Abs
    '/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
3. Lilly and Glenmark Pharmaceuticals Announce License Agreement
4. Lilly Receives NCQA Design Certification for Depression Care Management Program
5. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
7. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
8. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
9. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
10. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
11. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... April 16, 2015 A drug commonly taken to ... people with multiple sclerosis (MS), according to a study released ... Neurology,s 67th Annual Meeting in Washington, DC ... half of people with MS experience at some point in ... the nerve carrying vision from the eye to the brain ...
(Date:4/16/2015)...  Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) will report ... Wednesday, May 6, 2015, following the close of the U.S. ... call and live webcast on the same day at 5:00 ... the financial results.  To access the webcast ... "Investors" link.  Please log onto the webcast prior to the ...
(Date:4/16/2015)... 2015 Mallinckrodt plc (NYSE: MNK ... that it has completed its acquisition of Ikaria, ... billion. The Ikaria acquisition extends Mallinckrodt,s footprint in ... neonatal critical care with INOMAX ® (inhaled ... highly vulnerable patient population. It also accelerates Mallinckrodt,s ...
Breaking Medicine Technology:Epilepsy Drug May Preserve Eyesight for People with MS 2Alexza to Report 2015 First Quarter Financial Results and Provide Corporate Update on Wednesday, May 6, 2015 2Alexza to Report 2015 First Quarter Financial Results and Provide Corporate Update on Wednesday, May 6, 2015 3Mallinckrodt Completes Acquisition Of Ikaria 2Mallinckrodt Completes Acquisition Of Ikaria 3Mallinckrodt Completes Acquisition Of Ikaria 4Mallinckrodt Completes Acquisition Of Ikaria 5
... 2012  Sapio Sciences ( http://www.SapioSciences.com ) is pleased to ... release is the result of Sapio,s extensive experience in ... addresses MDx companies, operational needs in a single, integrated ... The molecular diagnostics market is experiencing ...
... Corporation ("Unilife" or "Company") (NASDAQ: UNIS ;  ASX: ... results for the fiscal 2012 second quarter ended December 31, ... Management has scheduled a conference call for ... 2012 ( Friday, February 10, 2012 at 8:30 AM ...
Cached Medicine Technology:Sapio Sciences Announces Exemplar Dx LIMS for Laboratories in the Burgeoning MDx Market 2Sapio Sciences Announces Exemplar Dx LIMS for Laboratories in the Burgeoning MDx Market 3Unilife Corporation to Announce Financial Results for Fiscal 2012 Second Quarter on Thursday, February 9, 2012 2Unilife Corporation to Announce Financial Results for Fiscal 2012 Second Quarter on Thursday, February 9, 2012 3
(Date:4/18/2015)... Canada (PRWEB) April 18, 2015 French ... emotions on food choices when he uttered, “Tell me ... you are.” Using food to cope with stress or ... by Queendom.com indicates otherwise. Data collected from ... genders fall victim to emotional eating, but for different ...
(Date:4/17/2015)... Rosetta Radiology is proud to now ... list of diagnostic imaging services. This solidifies them as ... Upper East Side of Manhattan. , The new imaging ... addition of PET-CT, combined with Rosetta’s state of the ... work with patients through several stages of the cancer ...
(Date:4/17/2015)... 17, 2015 Alcohol and Violence , ... notes that drinking and driving has been the focus ... same time, the link between alcohol and crime received ... and violence and sexual assault, and their relationship to ... NCADD, 5.3 million adults in America were drinking alcohol ...
(Date:4/17/2015)... From the day Dr. Todd Phillips founded ... organization has empowered young people to create meaningful change in ... fresh water and the Gospel to all of Liberia by ... 17 and 27, students, faculty and staff raised $21,000 through ... water and the Good News of Jesus. , During ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 Representatives Jim ... Diagnoses and Treatment Act HR 1849 in congress on ... rates and treatment for patients with the genetic disease. ... the past, would be the first to create a ... appropriate treatment of hereditary hemorrhagic telangiectasia. This would effectively ...
Breaking Medicine News(10 mins):Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 2Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 3Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 4Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 5Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 6Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 2Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 3Health News:The Last Well and Liberty U’s TEN Initiative raises $21,000 to Bring Fresh Water & The Gospel to 7,000 Liberians 2Health News:House Representatives Introduce Bill to Fight Genetic Disease 2
... that it has obtained approval to begin Phase 2 clinical ... IV metastatic melanoma, the most aggressive and deadly form of ... of Provecta in a total of 80 subjects. ... to 20 tumors in each subject. Additional treatment with Provecta ...
... 6 Nuvelo, Inc.,(Nasdaq: NUVO ) today ... in September: Bank of America 37th Annual ... PT Dr. Ted W. Love, Chairman and ... Breakout: http://www.veracast.com/webcasts/bas/37th-annual-2007/id89117822.cfm ...
... Distributed to 27 Providers to Purchase Vehicles, ... today said senior citizens and people with disabilities ... state,s investment of $2.1 million in 27,human service ... buy wheelchair-accessible vehicles. "Senior citizens and people ...
... Sept. 6 The sponsors of two of ... intention to bring,their organizations together within one health ... and the Vincentian Sisters of Charity announced,that they ... for profit,long term care facility operated by the ...
... LAUREL, N.J., Sept. 6 MedQuist Inc.,(Pink ... documentation,workflow technology and services, announces the re-launch ... The site has been completely redesigned with,assistance ... to Scott Bennett, MedQuist senior vice president ...
... Show 6 in 10 Students Suffer Chronic Back ... 6 With two weeks to go until ... across the United States are gearing up to ... event, sponsored by the American,Occupational Therapy Association (AOTA), ...
Cached Medicine News:Health News:Nuvelo Announces Upcoming Conference Calls, Webcasts and Conference Participation 2Health News:Governor Rendell Announces $2.1 Million Investment in Small Transit Vehicles 2Health News:Governor Rendell Announces $2.1 Million Investment in Small Transit Vehicles 3Health News:Area Health Care Providers Announce Plans to Integrate Services 2Health News:MedQuist Re-launches New, Improved Web Site 2Health News:Two Weeks Until National School Backpack Awareness Day 2
... DRE-200 ESU units use dedicated digital hardware ... processing data. This hardware allows parallel data ... throughput, measuring tissue impedance 5000 times per ... digitally, being converted to analog only in ...
... Mitek is the Market leader in soft ... Suture, DePuy Mitek has developed the latest ... open shoulder repair. ORTHOCORD Suture is as ... the market. Most importantly, ORTHOCORD Suture handles ...
... surgical gloves were designed with the surgeon ... barrier protection, and value. It offers comfort ... and dry hands. The broader, anatomical design ... micro-rough surface offers sensitivity and an effective ...
The Next Generation in Operating Room Equipment and Management Solutions is here Today. NuBoom is a self-contained, pedestal-mounted boom that houses medical, audio and visual equipment....
Medicine Products: